Perspectum a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and cancer recently announced the second close of its $55 million Series C funding round. Its flagship product is a diagnostic tool that assesses and monitors chronic liver disease.
Gilead to Present Data Across Viral Hepatitis and Liver Fibrosis at The Liver Meeting® 2022, Reinforcing Gilead as a Leader in Addressing Treatment Needs for People Living With Liver Disease
The U.S. is in the midst of a liver disease epidemic, but a new test may help turn the tide by leading to early detection of patients who may be at risk of disease progression